Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium
- PMID: 37625022
- PMCID: PMC10754158
- DOI: 10.1093/schbul/sbad112
Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium
Erratum in
-
Correction to: Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium.Schizophr Bull. 2024 Jan 1;50(1):228-229. doi: 10.1093/schbul/sbad135. Schizophr Bull. 2024. PMID: 37713624 Free PMC article. No abstract available.
References
-
- National Institute for Health and Care Excellence (NICE). Psychosis and Schizophrenia in Adults: Prevention and Management. London; 2014. - PubMed
-
- Allott K, McGorry PD, Yuen HP, et al. . The vitamins in psychosis study: a randomized, double-blind, placebo-controlled trial of the effects of vitamins B12, B6, and folic acid on symptoms and neurocognition in first-episode psychosis. Biol Psychiatry. 2019;86(1):35–44. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
